Vaccination Argumentative Essay

In June 2006, Gardasil, a Human Papillomavirus vaccine made by Merck & Co., was licensed for use and brought to the market (“HPV Vaccine”). Gardasil, which is given into a series of three injections, targets the main types of HPV. The types targeted are HPV 6, HPV 11, HPV 16 and HPV 18, which cause ninety percent of the genital warts and are the leading causes of cervical cancer (“Cervical Cancer Symptoms, Causes, Treatments”). Brought to the attention by researchers “combined, those strains affect an estimated 3 million women in the U.S” (“HPV Vaccine”). Since HPV is so common in the United States, the makers of Gardasil are trying to get a law approved that will make the shots mandatory. In 2006,

In addition, the immune system of most women will usually suppress or eliminate HPVs. This is very important because only an ongoing persistent infection has the potential to lead to cervical cancer (HPV). Eleven thousand cases of this kind of cancer were confirmed in 2007 in the United States; the amount undiagnosed is still unclear but believed to be in the tens of thousands. But to give some perspective of the problem you need to understand its effects on a global level. On the world wide scale cervical cancer strikes nearly half a million women each year, claiming more than a quarter of a million lives. “High risk” HPV types 16 and 18 are implicated in Seventy percent of cervical cancers and are hence selected for vaccine targets (The HPV).

Unfortunately, there is not a vaccination to protect against every type of cancer. However, the Gardasil vaccine guards against certain strands of HPV that cause 70% of cervical cancers in women. When caught early, the Human papillomavirus is treatable, but after the virus has developed into cancer, there is no cure. Therefore, the person affected begins a painful, uncertain journey to try to save her life. The Encyclopedia of Women’s Health states, “Human papillomavirus (HPV) infection may be the most common viral sexually transmitted disease (STD) in this country. As many as 30 million Americans are infected with HPV, and each year, an additional 1 million people become infected.” (“Human Papillomavirus”). When this many people are affected by a disease that can become cancer, it would be doltish not to use available resources to prevent it. “Nationally and internationally, the HPV vaccine will significantly

Prophylactic vaccination against high risk human papilloma virus 16 and 18 represents an exciting means of protection against HPV related malignancy. However, this strategy alone, even if there is a level of cross protection against other oncogenic viruses, cannot completely prevent cervical cancer. In some countries cervical screening programs have reduced the incidence of invasive cervical cancer by up to 80 percent although this decline has now reached a plateau with current cancers occurring in patients who have failed to attend for screening or where the sensitivity of the tests have proved inadequate. Cervical screening is inevitably associated with significant anxiety for the many women who require investigation and treatment following abnormal cervical cytology. However, it is vitally important to stress the need for continued cervical screening to complement vaccination in order to optimize prevention in vaccines and prevent cervical cancer in older women where the value of vaccination is currently unclear. It is likely that vaccination will ultimately change the natural history of HPV disease by reducing the influence of the highly oncogenic types HPV 16 and 18. In the long term this is likely to lead to an increase in recommended screening intervals. HPV vaccination may also reduce

This does not offer immunity against 30% of HPV strains that are at fault for causing cervical cancer. (“Comprehensive Cancer Information - National Cancer Institute.”) Although, cervical cancer may be the second most common form of cancer found in women, it is also the easiest form to cure. Based on information by Doctor Diane Harper, whom is the lead researcher for the Gardasil vaccine, the Gardasil shot is completely unnecessary. "70 percent of all HPV infections resolve themselves without treatment within a year. Within two years, the number climbs to 90 percent. Of the remaining 10 percent of HPV infections, only half will develop into cervical cancer, which leaves little need for the vaccine." Even if women do become vaccinated with Gardasil, typical pap smears and routine checkups are still going to be necessary. That alone has already been slicing the number of cervical cancer cases per year by four percent. (“ Weekly Blitz”) Merck, the creators of Gardasil, do not even know the current duration of the vaccine. They have estimated that the effectiveness of Gardasil will last for approximately five years, and a booster vaccine will be necessary. Furthermore, Merck has been known to do anything in order to sell their medicine, they created the drug Vioxx which was a total disaster. Merck did not allot nearly enough time to test the efficiency of the Gardasil shot. Over the course of a

I have chosen this paper since one of my goals during the Integrated Practicum was to gain knowledge about cancer prevention and management in the community settings. I believe that this article might increase my understanding about the usage of HPV Vaccines in prevention of various types of cancer.

At first glance, the guidelines seem logical because cervical cancer takes years to develop. However, a majority of the population is not vaccinated against the HPV virus, which is the lead cause of cervical cancer. Until

Gardasil has been tested in thousands of women and found to be nearly 100% effective in protecting against diseases caused by the four HPV types. Side effects are very uncommon and the occurrence is about 1%. Not only are HPV vaccinations safe, and effective but in today’s society it seems that they have become necessary. “An estimated 493,000 cervical cancer cases occur each year with 274,000 deaths. More than 80% of cervical cancer deaths worldwide occur in developing countries. Cervical cancer is the second most common cancer in women”. If there is a cure of this kind of epidemic, it is evident that it is necessary.

HPV vaccination is the most common used method for preventing cervical cancer in young girls ranging from age nine to eleven years old. The overall perception of the vaccine is positive by the public because of its wide use and support by state laws, school systems and medical associations. According to the American Pediatric Association the vaccine has an excellent safety record. (Nirvi,1) A reasonable amount of parents still feel skeptical about mandatory HPV vaccination on their kids and lack great knowledge regarding the vaccine’s effectiveness.

The medication Gardasil has proven to be safe for preventing cervical cancer, and has grown in popularity since its development. As of 2009, a grand total of 40 million

The Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI). There are over 100 types of HPV, but only 40 types affect the genital area and can cause genital warts and cervical cancer in women (“Human Papillomavirus (HPV) Vaccine”). In 2011 in the United States, 12,109 women were diagnosed with cervical cancer. Of those, 4,092 women died (“Cervical Cancer Statistics”). HPV is not only contracted from sexual intercourse, but also from skin to skin contact, including oral sex. The STI affects males and females involved in both homosexual and heterosexual sexual activities. Over 70 percent of sexually active individuals contract and carry HPV before the age of 80. In order to combat HPV two different brands of HPV vaccination – Gardasil and Cervarix – were created. Both include a vaccination plan of three shots over the course of six months. Gardasil was created by Merck & Co., and was licensed by the FDA in June 2006. The vaccine protects against HPV types 16 and 18, which lead to cervical cancer, as well as types 6 and 11, which cause 90% of genital warts. The FDA later approved Cervarix, created by GlaxoSmithKline, in 2009, which only protects against HPV types 16 and 18 (“Human Papillomavirus (HPV) Vaccine”). Originally, Gardasil was only approved for females, but three years after the release, the vaccine was approved

Cervical cancer is met with a vaccine with both pros and cons to suppress and annihilate it indefinitely. Although both Mike Adams and Arthur Allen inform the audience of the HPV vaccine, Adams vigorously argues, without evidence, that the vaccine is dangerous to humans while Allen is more sedate and discusses opposing sides to the vaccine. The HPV vaccine has its pros and cons to people that it has created debates to come down to the conclusion of a better solution for the drug companies and the people forcing to receive it. Though the HPV vaccine promises to cure cervical cancer, it has received its fair share of criticism.

Cervical cancer is a type of abnormal and malignant cell growth on the cervix (birth canal), which causes the common death for American Women. Infected by Human Papillomavirus (HPV) through sexual contact is the main contributor to cervical cancer. According to American Cancer Society’s (ACS) (2017) estimation, around 12,820 people will newly have cervical cancer and about 4,210 people will die from that in 2017. Therefore, it is urgent to decrease the rate of cervical cancer at women. A three-shot Gardasil series vaccine approved by the FDA for girls started to prevent cervical cancer in 2006. There are more than forty types of HPVs and the majority

The HPV vaccine is cancer prevention. Over thousands of cases of HPV cancers are detected every year in men and women. The HPV vaccination is important because it can prevent these cancers. The United States Food and Drug Administration approved this vaccine and it is one hundred percent safe. This vaccine is preventive care for the second leading cancer in women. It has been proven to be one hundred percent effective in prevention of cervical cancer, but the vaccine must be given to children between the age of 11 -17 before they become sexually active. After the age seventeen with young women most become sexually active and receive their first pap smear from their gynecologist, receiving the vaccine at this point is not as effective in prevention of cancers. Another benefit of receiving the vaccine during adolescent, is it supports people who may not have the medical knowledge or access to regular medical services.

Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).